[Clinical utility of angiotensin II receptor antagonist].
Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.
5-HT3 receptor ligands lack modulatory influence on acetycholine release in rat entorhinal cortex